Skip to content
Search

Latest Stories

Focus on supporting patients to wait well, Senedd committee recommends

The Health and Social Care Committee of the Welsh Parliament have published a report with several recommendations to address the rising issue of waiting time for diagnosis and therapy in Wales.

Since Covid-19 pandemic Wales has witnessed a significant increase in the NHS waiting lists for diagnostic and therapy appointments and surgical treatment. The report noted that the equivalent of around one in five of the Welsh population is on an NHS waiting list, and around 37 per cent of people waiting to start treatment have been waiting over 9 months.


As part of its recommendations, the Senedd committee has asked the Welsh government to include ‘a focus on supporting patients to wait well’ in its planned care recovery plan, in addition to setting out how the waiting times backlog will be addressed.

“It is crucial that the Welsh Government and health boards put in place robust plans to tackle the backlog, and to ensure that people receive the care and treatment they need as soon as possible. This must include arrangements to support people who are waiting, and to communicate with them effectively so that no one feels forgotten,” Russell George MS, chair of the Health and Social Care Committee, said.

The committee also recommended the Minister for Health and Social Services to outline “what contribution the new community pharmacy contract will make to tackling health inequalities, including what scope it provides for pharmacy teams to refer patients into other health services and how it will contribute to raising awareness of the services and support community pharmacies can provide.”

The report welcomed the community pharmacy pilot in the Hywel Dda University Health Board area, applauding the effort being made “to ensure that all contacts that our health services have with their communities provide opportunities to support people’s health and wellbeing.”

“We agree with Community Pharmacy Wales that access to shared patient records, with suitable data protection arrangements in place, could facilitate this and help to provide more seamless and patient-centred services,” the report added.

Other recommendations include:

  • The services in place for people who are waiting for diagnostics and treatment, particularly pain management support.
  • Access to psychological therapies and emotional support for those who may be experiencing anxiety or distress as a result of long waiting times.
  • The contribution the third sector can make in providing peer support and information to patients waiting on an NHS waiting list.
  • The effectiveness of messaging and engagement with the public about the demands on the service and the importance of seeking care promptly.
  • The extent to which inequalities exist in the elective backlog, with deprived areas facing disproportionately large waiting lists per head of population compared to least deprived areas.
  • Plans to fully restore planned NHS care in Wales.

In response to the report, Darren Hughes, director of the Welsh NHS Confederation, emphasized: “Long term workforce challenges must be addressed by governments if we are to reduce waiting times and have a health and care service the public deserves - and that politicians continue to promise. We also need certainty around future financial settlements, revenue and capital investments to be able to plan and deliver on the capacity expansion needed to meet demand.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less